These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3638 related articles for article (PubMed ID: 6499732)
1. [Proliferative activity and cytotoxic effect of mouse lymphocytes during the growth of transplanted melanoma B-16]. Korosteleva TA; Veresova OV Eksp Onkol; 1984; 6(1):53-5. PubMed ID: 6499732 [TBL] [Abstract][Full Text] [Related]
2. [Cytotoxic immunity indices of melanoma B16 growth in mice]. Korosteleva TA; Veresova OV Vopr Onkol; 1980; 26(1):67-70. PubMed ID: 7355591 [TBL] [Abstract][Full Text] [Related]
3. [Dynamics of natural killer activity during the growth of melanoma B16 in mice]. Koval'chuk LV; Sokolova EV; Cheknev SB; Deev VV Dokl Akad Nauk SSSR; 1986; 288(5):1267-70. PubMed ID: 3732037 [No Abstract] [Full Text] [Related]
4. Tumour-activated macrophages as effector cells in a tumour neutralization assay in vivo. Olstad R; Kaplan G; Seljelid R Acta Pathol Microbiol Immunol Scand C; 1983 Oct; 91(5):305-14. PubMed ID: 6362328 [TBL] [Abstract][Full Text] [Related]
5. Limiting dilution analysis of the frequency of human T cells and large granular lymphocytes proliferating in response to interleukin 2. I. The effect of lectin on the proliferative frequency and cytotoxic activity of cultured lymphoid cells. Vose BM; Bonnard GD J Immunol; 1983 Feb; 130(2):687-93. PubMed ID: 6600251 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of effector cells mediating the antitumor action of glucan. Cook JA; Taylor D; Cohen C; Hoffmann EO; Rodrigue J; Malshet V; Di Luzio NR J Reticuloendothel Soc; 1977 Jul; 22(1):21-34. PubMed ID: 330854 [No Abstract] [Full Text] [Related]
7. The augmenting effect of OK432-stimulated B cells on the in vitro generation of anti-tumor cytotoxic T lymphocytes from tumor-draining lymph node cells: the possible role of interleukin-12. Shinomiya Y; Harada M; Tamada K; Kurosawa S; Okamoto T; Terao H; Takenoyama M; Ito O; Hirashima C; Li T; Shirakusa T; Nomoto K In Vivo; 1997; 11(1):1-8. PubMed ID: 9067765 [TBL] [Abstract][Full Text] [Related]
8. Activation of murine thymocytes in vivo. Part II: Study of blastogenesis, the synthesis of macromolecules and the cytotoxic response after stimulation with phytohemagglutinin. Chaudhuri TK; Chakravarty AK Lymphology; 1986 Sep; 19(3):117-24. PubMed ID: 2431234 [TBL] [Abstract][Full Text] [Related]
9. Inhibition by lymphoid cellular factors of the immunological cytotoxicity against a syngeneic tumour. Lafontaine N; Firket H Pathol Eur; 1976; 11(2):147-50. PubMed ID: 958732 [TBL] [Abstract][Full Text] [Related]
10. Vaccination with B16 melanoma cells expressing a secreted form of interleukin-1beta induces tumor growth inhibition and an enhanced immunity against the wild-type B16 tumor. Björkdahl O; Dohlsten M; Sjögren HO Cancer Gene Ther; 2000 Oct; 7(10):1365-74. PubMed ID: 11059695 [TBL] [Abstract][Full Text] [Related]
11. [The mechanism of anti-tumor immune response against mouse melanoma to xenogeneic vaccination]. Luo F; Mao YQ; Kan B; He QM; Jiang Y; Peng F; Yang L; Tian L Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Nov; 35(6):757-60. PubMed ID: 15573746 [TBL] [Abstract][Full Text] [Related]
12. [Splenocyte functional activity in mice growing the syngeneic transplantable hepatoma 22a]. Kiseleva EP; Malygin AM Tsitologiia; 1984 Dec; 26(12):1409-15. PubMed ID: 6335612 [TBL] [Abstract][Full Text] [Related]
13. Neem (Azadirachta indica) leaf mediated immune activation causes prophylactic growth inhibition of murine Ehrlich carcinoma and B16 melanoma. Baral R; Chattopadhyay U Int Immunopharmacol; 2004 Mar; 4(3):355-66. PubMed ID: 15037213 [TBL] [Abstract][Full Text] [Related]
14. Lysis of syngeneic solid tumor cells by alloantigen stimulated mouse T and non-T cells. Paciucci PA; Macphail S; Zarling JM; Bach FH J Immunol; 1980 Jan; 124(1):370-5. PubMed ID: 6765969 [No Abstract] [Full Text] [Related]
15. Induction of Lyt-2+ cytotoxic T lymphocytes following primary and secondary Salmonella infection. Pope M; Kotlarski I; Doherty K Immunology; 1994 Feb; 81(2):177-82. PubMed ID: 7512524 [TBL] [Abstract][Full Text] [Related]
16. In vitro augmentation of human natural cytotoxic activity. Potter MR; Moore M Clin Exp Immunol; 1981 May; 44(2):332-41. PubMed ID: 7307338 [TBL] [Abstract][Full Text] [Related]
18. Modulation of immune effector cell cytolytic activity and tumour growth inhibition in vivo by Ukrain (NSC 631570). Liepins A; Nowicky JW Drugs Exp Clin Res; 1996; 22(3-5):103-13. PubMed ID: 8899312 [TBL] [Abstract][Full Text] [Related]
19. Early-appearing tumour-infiltrating natural killer cells play a crucial role in the generation of anti-tumour T lymphocytes. Kurosawa S; Harada M; Matsuzaki G; Shinomiya Y; Terao H; Kobayashi N; Nomoto K Immunology; 1995 Jun; 85(2):338-46. PubMed ID: 7642226 [TBL] [Abstract][Full Text] [Related]
20. In vivo modulation of thymus-derived lymphocytes with monoclonal antibodies in mice. II. Separation of natural killer cells and cytotoxic T cells. Le Gros GS; Herbert AG; Watson JD Immunology; 1984 Jan; 51(1):103-13. PubMed ID: 6606615 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]